Literature DB >> 16951696

Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling.

Diego Kyburz1, Fabia Brentano, Steffen Gay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16951696     DOI： 10.1038/ncprheum0292

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  48 in total

Review 1.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

Review 2.  Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.

Authors:  Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 3.  Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease.

Authors:  Clifton O Bingham
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

Review 4.  Regulatory T cells as therapeutic targets in rheumatoid arthritis.

Authors:  Jonathan H Esensten; David Wofsy; Jeffrey A Bluestone
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

Review 5.  Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

Authors:  Jing Li; Xiaohui Wang; Fengchun Zhang; Hang Yin
Journal:  Pharmacol Ther       Date:  2013-03-24       Impact factor: 12.310

6.  PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus.

Authors:  Begum Horuluoglu; Defne Bayik; Neslihan Kayraklioglu; Emilie Goguet; Mariana J Kaplan; Dennis M Klinman
Journal:  J Autoimmun       Date:  2019-01-22       Impact factor: 7.094

7.  Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Authors:  Entela Nuri; Mara Taraborelli; Laura Andreoli; Marta Tonello; Maria Gerosa; Antonia Calligaro; Lorenza Maria Argolini; Rajesh Kumar; Vittorio Pengo; Pier Luigi Meroni; Amelia Ruffatti; Angela Tincani
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 8.  Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article.

Authors:  Annamaria Mascolo; Pasquale Maria Berrino; Pietro Gareri; Alberto Castagna; Annalisa Capuano; Ciro Manzo; Liberato Berrino
Journal:  Inflammopharmacology       Date:  2018-06-09       Impact factor: 4.473

Review 9.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

10.  A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Toi Pham Van; Sue J Lee; Jeremy Farrar; Bridget Wills; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.